Northwestern Mutual Wealth Management CO Neurocrine Biosciences Inc Transaction History

Northwestern Mutual Wealth Management CO

$112 Billion
Q3 2024

A detailed history of Northwestern Mutual Wealth Management CO transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 1,137 shares of NBIX stock, worth $170,663. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,137

Previous 757 50.2%

Holding current value

$170,663

Previous $104,000 25.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$114.58 - $153.15 $43,540 - $58,197	380 Added 50.2%	1,137 $130,000
Q2 2024 Aug 15, 2024	BUY	$130.86 - $143.19 $6,543 - $7,159	50 Added 7.07%	757 $104,000
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $782 - $862	6 Added 0.86%	707 $97,000
Q4 2023 Feb 13, 2024	BUY	$106.07 - $132.76 $38,927 - $48,722	367 Added 109.88%	701 $92,000
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $4,889 - $6,089	-52 Reduced 13.47%	334 $37,000
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $3,491 - $4,089	-39 Reduced 9.18%	386 $36,000
Q1 2023 May 15, 2023	SELL	$94.11 - $123.02 $13,645 - $17,837	-145 Reduced 25.44%	425 $43,000
Q4 2022 Feb 21, 2023	SELL	$106.72 - $127.06 $254,313 - $302,783	-2,383 Reduced 80.7%	570 $68,000
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $4,141 - $4,851	-45 Reduced 1.5%	2,953 $314,000
Q2 2022 Aug 04, 2022	BUY	$75.79 - $100.07 $4,850 - $6,404	64 Added 2.18%	2,998 $292,000
Q1 2022 May 09, 2022	SELL	$72.45 - $94.81 $6,810 - $8,912	-94 Reduced 3.1%	2,934 $275,000
Q4 2021 Feb 03, 2022	BUY	$79.65 - $106.22 $7,805 - $10,409	98 Added 3.34%	3,028 $258,000
Q3 2021 Nov 15, 2021	BUY	$86.18 - $99.03 $4,309 - $4,951	50 Added 1.74%	2,930 $281,000
Q2 2021 Aug 13, 2021	SELL	$89.43 - $102.27 $109,283 - $124,973	-1,222 Reduced 29.79%	2,880 $281,000
Q1 2021 May 14, 2021	BUY	$87.57 - $119.4 $255,091 - $347,812	2,913 Added 245.0%	4,102 $399,000
Q4 2020 Feb 12, 2021	SELL	$86.91 - $108.33 $201,631 - $251,325	-2,320 Reduced 66.12%	1,189 $114,000
Q3 2020 Nov 13, 2020	BUY	$96.16 - $135.15 $174,338 - $245,026	1,813 Added 106.9%	3,509 $337,000
Q2 2020 Aug 14, 2020	BUY	$85.09 - $130.36 $137,590 - $210,792	1,617 Added 2046.84%	1,696 $207,000
Q1 2020 May 08, 2020	BUY	$75.11 - $113.76 $1,276 - $1,933	17 Added 27.42%	79 $7,000
Q4 2019 Feb 13, 2020	BUY	$86.8 - $118.57 $173 - $237	2 Added 3.33%	62 $7,000
Q3 2019 Nov 12, 2019	SELL	$83.82 - $101.5 $2,179 - $2,639	-26 Reduced 30.23%	60 $5,000
Q1 2019 May 10, 2019	SELL	$69.31 - $91.53 $12,059 - $15,926	-174 Reduced 66.92%	86 $7,000
Q4 2018 Feb 12, 2019	BUY	$68.32 - $124.36 $11,204 - $20,395	164 Added 170.83%	260 $19,000
Q2 2018 Aug 10, 2018	SELL	$75.3 - $105.99 $1,129 - $1,589	-15 Reduced 13.51%	96 $9,000
Q1 2018 May 14, 2018	BUY	$75.88 - $92.43 $1,138 - $1,386	15 Added 15.63%	111 $9,000
Q2 2017 Aug 10, 2017	BUY	N/A	96	96 $4,000

Others Institutions Holding NBIX

# of Institutions

637

Shares Held

93.8M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.4B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.

Account

Northwestern Mutual Wealth Management CO Neurocrine Biosciences Inc Transaction History